ELOVL4 Antikörper

Produktnummer ABIN550372

Produktdetails anti-ELOVL4 Antikörper

Target: ELOVL4 (ELOVL Fatty Acid Elongase 4 (ELOVL4))

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser ELOVL4 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB)

Verwendungszweck: Rabbit polyclonal antibody raised against synthetic peptide of ELOVL4.

Kreuzreaktivität: Human

Produktmerkmale: Antibody Reactive Against Synthetic Peptide.

Immunogen: A synthetic peptide corresponding to human ELOVL4.

Anwendungsinformationen

Applikationshinweise: Western Blot (1-5 μg/mL)
The optimal working dilution should be determined by the end user.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Buffer: In PBS (0.08 % sodium azide)

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: -20 °C

Informationen zur Lagerung: Store at -20°C.
Aliquot to avoid repeated freezing and thawing.

Referenzen für anti-ELOVL4 Antikörper (ABIN550372)

Vasireddy, Uchida, Salem, Kim, Mandal, Reddy, Bodepudi, Alderson, Brown, Hama, Dlugosz, Elias, Holleran, Ayyagari: "Loss of functional ELOVL4 depletes very long-chain fatty acids (> or =C28) and the unique omega-O-acylceramides in skin leading to neonatal death." in: Human molecular genetics, Vol. 16, Issue 5, pp. 471-82, (2007) (PubMed).

DeAngelis, Ji, Kim, Adams, Capone, Ott, Miller, Dryja: "Cigarette smoking, CFH, APOE, ELOVL4, and risk of neovascular age-related macular degeneration." in: Archives of ophthalmology, Vol. 125, Issue 1, pp. 49-54, (2007) (PubMed).

Kobayashi, Zadravec, Jacobsson: "ELOVL2 overexpression enhances triacylglycerol synthesis in 3T3-L1 and F442A cells." in: FEBS letters, Vol. 581, Issue 17, pp. 3157-63, (2007) (PubMed).

Details zu ELOVL4

Target: ELOVL4 (ELOVL Fatty Acid Elongase 4 (ELOVL4))

Andere Bezeichnung: ELOVL4 (ELOVL4 Produkte)

Synonyme: elovl4 antikoerper, MGC122553 antikoerper, ADMD antikoerper, CT118 antikoerper, ISQMR antikoerper, STGD2 antikoerper, STGD3 antikoerper, elongation of very long chain fatty acids protein 4 antikoerper, ELOVL fatty acid elongase 4 antikoerper, elongation of very long chain fatty acids (FEN1/Elo2, SUR4/Elo3, yeast)-like 4 antikoerper, CpipJ_CPIJ002114 antikoerper, CpipJ_CPIJ003687 antikoerper, CpipJ_CPIJ011025 antikoerper, CpipJ_CPIJ013819 antikoerper, ELOVL4 antikoerper, elovl4 antikoerper, Elovl4 antikoerper

Gen-ID: 6785